1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porters Fiver Forces Analysis 39
3 Segmentation of North America Market by Drug Type 43
3.1 Market Overview by Drug Type 43
3.2 Small Molecule Drugs 45
3.3 Biologic Drugs 46
4 Segmentation of North America Market by Service 47
4.1 Market Overview by Service 47
4.2 Medicinal Chemical Services 49
4.3 Biological Services 50
4.4 Drug Metabolism and Pharmacokinetics (DMPK) Services 51
4.5 Other Pharmaceutical Services 52
5 Segmentation of North America Market by Process 53
5.1 Market Overview by Process 53
5.2 Target Selection 55
5.3 Target Validation 56
5.4 Hit-To-Lead Identification 57
5.5 Lead Optimization 58
5.6 Candidate Validation 59
6 Segmentation of North America Market by Technology 60
6.1 Market Overview by Technology 60
6.2 High Throughput Screening 62
6.3 Combinatorial Chemistry 63
6.4 Pharmacogenomics and Pharmacogenetics 64
6.5 Nanotechnology 65
6.6 Bioanalytical Instruments 66
6.7 Biochips 67
6.8 Bioinformatics 68
6.9 Other Technologies 69
7 Segmentation of North America Market by Therapeutic Area 70
7.1 Market Overview by Therapeutic Area 70
7.2 Oncology 72
7.3 Neurology 73
7.4 Infectious and Immune System Diseases 74
7.5 Digestive System Diseases 75
7.6 Cardiovascular Diseases 76
7.7 Diabetes 77
7.8 Respiratory Disease 78
7.9 Other Therapeutic Areas 79
8 Segmentation of North America Market by End User 80
8.1 Market Overview by End User 80
8.2 Pharmaceutical Companies 82
8.3 Contract Research Organizations (CROs) 83
8.4 Research Institutes 84
8.5 Other End Users 85
9 North America Market 2019-2030 by Country 86
9.1 Overview of North America Market 86
9.2 U.S. 89
9.3 Canada 95
9.4 Mexico 97
10 Competitive Landscape 99
10.1 Overview of Key Vendors 99
10.2 New Product Launch, Partnership, Investment, and M&A 102
10.3 Company Profiles 103
Abbott Laboratories Inc. 103
Agilent Technologies Inc. 105
Astrazeneca plc 106
Bayer AG 107
Charles River Laboratories International Inc. 108
Eli Lilly and Company 109
F. Hoffmann-La Roche Ltd 110
GlaxoSmithKline PLC 111
Merck & Co. Inc. 112
Novartis AG 113
Pfizer Inc. 114
Shimadzu Corp 115
Thermo Fisher Scientific Inc. 116
RELATED REPORTS 117